Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Patent: 8,703,956

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,703,956
Title:Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid
Abstract: The invention relates to a stable amorphous form of (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid and its use in the treatment of conditions mediated by the action of PGD.sub.2 at the CRTH2 receptor.
Inventor(s): Betancourt; Aimesther (Laval, CA), Lemieux; Marc (Laval, CA), Thibert; Roch (Laval, CA)
Assignee: Atopix Therapeutics Limited (Abingdon, Oxon, GB)
Application Number:13/414,328
Patent Claims:see list of patent claims

Details for Patent 8,703,956

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Glaxosmithkline NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS 761122 001 2019-06-06   Start Trial Atopix Therapeutics Limited (Abingdon, Oxon, GB) 2031-03-07 RX search
Glaxosmithkline Llc NUCALA mepolizumab INJECTABLE;SUBCUTANEOUS LYOPHILIZED POWER 125526 001 2015-11-04   Start Trial Atopix Therapeutics Limited (Abingdon, Oxon, GB) 2031-03-07 RX Orphan search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20   Start Trial Atopix Therapeutics Limited (Abingdon, Oxon, GB) 2031-03-07 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.